BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 32810752)

  • 21. The nuclear exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage.
    van der Watt PJ; Leaner VD
    Biochim Biophys Acta; 2011 Jul; 1809(7):316-26. PubMed ID: 21683812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying drug-target selectivity of small-molecule CRM1/XPO1 inhibitors by CRISPR/Cas9 genome editing.
    Neggers JE; Vercruysse T; Jacquemyn M; Vanstreels E; Baloglu E; Shacham S; Crochiere M; Landesman Y; Daelemans D
    Chem Biol; 2015 Jan; 22(1):107-16. PubMed ID: 25579209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRM1 inhibitory and antiproliferative activities of novel 4'-alkyl substituted klavuzon derivatives.
    Kanbur T; Kara M; Kutluer M; Şen A; Delman M; Alkan A; Otaş HO; Akçok İ; Çağır A
    Bioorg Med Chem; 2017 Aug; 25(16):4444-4451. PubMed ID: 28689976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new brominated chalcone derivative suppresses the growth of gastric cancer cells in vitro and in vivo involving ROS mediated up-regulation of DR5 and 4 expression and apoptosis.
    Zhang S; Li T; Zhang Y; Xu H; Li Y; Zi X; Yu H; Li J; Jin CY; Liu HM
    Toxicol Appl Pharmacol; 2016 Oct; 309():77-86. PubMed ID: 27594528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function.
    Knauer SK; Bier C; Habtemichael N; Stauber RH
    EMBO Rep; 2006 Dec; 7(12):1259-65. PubMed ID: 17099693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection.
    Lu C; Figueroa JA; Liu Z; Konala V; Aulakh A; Verma R; Cobos E; Chiriva-Internati M; Gao W
    Curr Cancer Drug Targets; 2015; 15(7):575-92. PubMed ID: 26324128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caffeic acid phenethyl ester (CAPE) revisited: Covalent modulation of XPO1/CRM1 activities and implication for its mechanism of action.
    Wu S; Zhang K; Qin H; Niu M; Zhao W; Ye M; Zou H; Yang Y
    Chem Biol Drug Des; 2017 May; 89(5):655-662. PubMed ID: 27863053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leptomycin B alters the subcellular distribution of CRM1 (Exportin 1).
    Rahmani K; Dean DA
    Biochem Biophys Res Commun; 2017 Jun; 488(2):253-258. PubMed ID: 28412356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer.
    Wang Y; Wang Y; Xiang J; Ji F; Deng Y; Tang C; Yang S; Xi Q; Liu R; Di W
    Cancer Lett; 2014 Feb; 343(1):6-13. PubMed ID: 24018641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.
    Zhang L; Tian W; Kim S; Ding W; Tong Y; Chen S
    Drug Des Devel Ther; 2015; 9():79-92. PubMed ID: 25565771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone.
    Muqbil I; Aboukameel A; Elloul S; Carlson R; Senapedis W; Baloglu E; Kauffman M; Shacham S; Bhutani D; Zonder J; Azmi AS; Mohammad RM
    Cancer Lett; 2016 Dec; 383(2):309-317. PubMed ID: 27693556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition.
    Wang YX; Cai H; Jiang G; Zhou TB; Wu H
    Asian Pac J Cancer Prev; 2014; 15(16):6791-8. PubMed ID: 25169527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel chalcone derivative S17 induces apoptosis through ROS dependent DR5 up-regulation in gastric cancer cells.
    Zhang S; Li T; Zhang L; Wang X; Dong H; Li L; Fu D; Li Y; Zi X; Liu HM; Zhang Y; Xu H; Jin CY
    Sci Rep; 2017 Aug; 7(1):9873. PubMed ID: 28852176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRM1 Inhibition Promotes Cytotoxicity in Ewing Sarcoma Cells by Repressing EWS-FLI1-Dependent IGF-1 Signaling.
    Sun H; Lin DC; Cao Q; Guo X; Marijon H; Zhao Z; Gery S; Xu L; Yang H; Pang B; Lee VK; Lim HJ; Doan N; Said JW; Chu P; Mayakonda A; Thomas T; Forscher C; Baloglu E; Shacham S; Rajalingam R; Koeffler HP
    Cancer Res; 2016 May; 76(9):2687-97. PubMed ID: 26956669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor.
    Subhash VV; Yeo MS; Wang L; Tan SH; Wong FY; Thuya WL; Tan WL; Peethala PC; Soe MY; Tan DSP; Padmanabhan N; Baloglu E; Shacham S; Tan P; Koeffler HP; Yong WP
    Sci Rep; 2018 Aug; 8(1):12248. PubMed ID: 30115935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways.
    Liu X; Chong Y; Tu Y; Liu N; Yue C; Qi Z; Liu H; Yao Y; Liu H; Gao S; Niu M; Yu R
    J Hematol Oncol; 2016 Oct; 9(1):108. PubMed ID: 27733172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 1 parathyroid hormone receptor (PTH1R) nuclear trafficking: regulation of PTH1R nuclear-cytoplasmic shuttling by importin-alpha/beta and chromosomal region maintenance 1/exportin 1.
    Pickard BW; Hodsman AB; Fraher LJ; Watson PH
    Endocrinology; 2007 May; 148(5):2282-9. PubMed ID: 17317770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trans-chalcone increases p53 activity via DNAJB1/HSP40 induction and CRM1 inhibition.
    Silva G; Marins M; Chaichanasak N; Yoon Y; Fachin AL; Pinhanelli VC; Regasini LO; Dos Santos MB; Ayusso GM; Marques BC; Wu WW; Phue JN; Shen RF; Baek SJ
    PLoS One; 2018; 13(8):e0202263. PubMed ID: 30118500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inducement effect of 9-cis retinoic acid on cell cycle arrest and apoptosis of gastric carcinoma cell line MGC803 and its mechanism].
    Xu RC; Zhou YH; Hu WL
    Ai Zheng; 2006 Dec; 25(12):1483-7. PubMed ID: 17166371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRM1 is a direct cellular target of the natural anti-cancer agent plumbagin.
    Liu X; Niu M; Xu X; Cai W; Zeng L; Zhou X; Yu R; Xu K
    J Pharmacol Sci; 2014; 124(4):486-93. PubMed ID: 24739265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.